Orchard Therapeutics plc Quarterly Operating Margin in % from Q4 2022 to Q3 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Orchard Therapeutics plc quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q3 2023.
  • Orchard Therapeutics plc Operating Margin for the quarter ending September 30, 2023 was -467 %.
  • Orchard Therapeutics plc annual Operating Margin for 2022 was -561 %, a 93.3% increase from 2021.
  • Orchard Therapeutics plc annual Operating Margin for 2021 was -8.38K %, a 38.6% decline from 2020.
  • Orchard Therapeutics plc annual Operating Margin for 2020 was -6.05K %, a 12.1% increase from 2019.
Operating Margin, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -467 Jul 1, 2023 Sep 30, 2023
Q2 2023 -497 Apr 1, 2023 Jun 30, 2023
Q1 2023 -630 Jan 1, 2023 Mar 31, 2023
Q4 2022 -561 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.